CHA
HELP

Carmichael Hill & Associates’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Carmichael Hill & Associates’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13
Closed -$136 – 783
2024
Q2 		$136 Buy
+13
New +$170 ﹤0.01% 766

Other funds holding HELP

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.73B AUM 24.11% 1-Year Est. Return

Carmichael Hill & Associates's HELP Position: Q3 2024 in Review

Carmichael Hill & Associates sold out of Helus Pharma Inc. Common Stock (HELP) in Q3 2024, closing a stake of 13 shares — an estimated $136 sold.

Carmichael Hill & Associates first reported a position in HELP in Q2 2024 and held it in 1 quarter. The position peaked at $136 in Q2 2024. 46 funds tracked by Wall St. Rank hold HELP as of Q3 2024.

  • Carmichael Hill & Associates reported no remaining Helus Pharma Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Carmichael Hill & Associates sold 13 Helus Pharma Inc. Common Stock shares in Q3 2024, an estimated $136.
  • Carmichael Hill & Associates first reported a position in Helus Pharma Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • Carmichael Hill & Associates's Helus Pharma Inc. Common Stock position peaked at $136 in Q2 2024.
  • 46 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.